The Use and Usefulness of Point-of-care Tests in Patients with Pharyngotonsillitis - an Observational Study in Primary Health Care

Overview

Journal BMC Prim Care

Specialties Health Services
Public Health

Date 2024 Jan 6

PMID 38184547

Authors

Jon Pallon

Martin Sundqvist

Katarina Hedin

Affiliations

Soon will be listed here.

Abstract

Background: Rapid antigen detection tests (RADT) for Group A streptococci (GAS) and point-of-care tests for C-reactive protein (CRP) are commonly used in patients with pharyngotonsillitis in Sweden and Denmark although CRP testing is not supported by guidelines. We aimed to describe (1) the proportion of patients tested with RADT and/or CRP, (2) the relation between test results and antibiotic prescribing, and (3) the association between CRP level and microbial aetiology.

Methods: We used a post-hoc-analysis of data collected in primary health care in a prospective aetiological study of 220 patients 15-45 years old diagnosed with pharyngotonsillitis. The outcomes of RADTs and CRP tests were related to antibiotic prescribing and microbial aetiology.

Results: A RADT was used in 94% of the patients. A CRP test was used in 50% of the patients but more commonly in those with a negative RADT (59%) than in those with a positive RADT (38%) (p = 0.005). Most (74%) CRP tests were used in patients with a negative RADT. Antibiotic prescribing differed greatly between patients with a positive RADT (96%) and patients with a negative RADT (17%) (p < 0.001). In patients with a negative RADT, there was a positive association between CRP value and antibiotic prescribing (OR 1.05; 95% CI 1.02-1.07; p < 0.001). Patients with CRP values ≤ 30 mg/l were seldomly prescribed antibiotics. Patients with GAS in culture had the highest median CRP (46 mg/l), which was higher than in patients without GAS (8 mg/l; p < 0.001). However, the positive predictive value for GAS never exceeded 0.60 (95% CI 0.31-0.83) at the investigated CRP levels.

Conclusions: The widespread use of tests is a major deviation from national guidelines. Most CRP tests were used in patients with a negative RADT, suggesting a belief in the added value of a CRP test, and the CRP result seemed to influence antibiotic prescribing. However, as an aetiological test, CRP is not useful for predicting GAS.

Citing Articles

Use of point-of-care tests in pharyngotonsillitis - a registry-based study in primary health care.

Pallon J, Hedin K Scand J Prim Health Care. 2024; 43(1):164-172.

PMID: 39460385 PMC: 11834818. DOI: 10.1080/02813432.2024.2416671.

Factors behind Antibiotic Therapy: A Survey of Primary Care Pediatricians in Lombardy.

Perrone P, Picca M, Carrozzo R, Agostoni C, Marchisio P, Milani G Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200700 PMC: 11354739. DOI: 10.3390/ijerph21081091.

References

Lindbaek M, Hoiby E, Lermark G, Steinsholt I, Hjortdahl P . Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract. 2005; 55(517):615-9. PMC: 1463235. View

Reinholdt K, Rusan M, Hansen P, Klug T . Management of sore throat in Danish general practices. BMC Fam Pract. 2019; 20(1):75. PMC: 6545212. DOI: 10.1186/s12875-019-0970-3. View

Hedin K, Bieber L, Lindh M, Sundqvist M . The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium necrophorum is commonly found. Clin Microbiol Infect. 2015; 21(3):263.e1-7. PMC: 7128797. DOI: 10.1016/j.cmi.2014.08.020. View

Cohen J, Bertille N, Cohen R, Chalumeau M . Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016; 7:CD010502. PMC: 6457926. DOI: 10.1002/14651858.CD010502.pub2. View

Fine A, Nizet V, Mandl K . Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012; 172(11):847-52. PMC: 3627733. DOI: 10.1001/archinternmed.2012.950. View

Kunnamo A, Korppi M, Helminen M . Tonsillitis in children: unnecessary laboratory studies and antibiotic use. World J Pediatr. 2015; 12(1):114-7. DOI: 10.1007/s12519-015-0054-y. View

Putto A, Meurman O, Ruuskanen O . C-reactive protein in the differentiation of adenoviral, Epstein-Barr viral and streptococcal tonsillitis in children. Eur J Pediatr. 1986; 145(3):204-6. DOI: 10.1007/BF00446066. View

Christensen A, Thomsen M, Ovesen T, Klug T . Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis?. Scand J Infect Dis. 2014; 46(5):376-83. DOI: 10.3109/00365548.2014.885656. View

Mercaldo N, Lau K, Zhou X . Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2006; 26(10):2170-83. DOI: 10.1002/sim.2677. View

10.

Escadafal C, Incardona S, Fernandez-Carballo B, Dittrich S . The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings. BMJ Glob Health. 2020; 5(5). PMC: 7259834. DOI: 10.1136/bmjgh-2020-002396. View

11.

Koo C, Eisenhut M . Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Can inflammatory markers distinguish streptococcal from viral tonsillitis?. Emerg Med J. 2011; 28(8):715-7. DOI: 10.1136/emj.2010.099531. View

12.

van der Velden A, van de Pol A, Bongard E, Cianci D, Aabenhus R, Balan A . Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countries. BJGP Open. 2021; 6(2). PMC: 9447323. DOI: 10.3399/BJGPO.2021.0212. View

13.

Joseph P, Godofsky E . Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use. Open Forum Infect Dis. 2018; 5(2):ofy024. PMC: 5815119. DOI: 10.1093/ofid/ofy024. View

14.

Hjortdahl P, Melbye H . Does near-to-patient testing contribute to the diagnosis of streptococcal pharyngitis in adults?. Scand J Prim Health Care. 1994; 12(2):70-6. DOI: 10.3109/02813439409003678. View

15.

Little P, Hobbs F, Moore M, Mant D, Williamson I, McNulty C . Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management). BMJ. 2013; 347:f5806. PMC: 3805475. DOI: 10.1136/bmj.f5806. View

16.

Alper Z, Uncu Y, Akalin H, Ercan I, Sinirtas M, Bilgel N . Diagnosis of acute tonsillopharyngitis in primary care: a new approach for low-resource settings. J Chemother. 2013; 25(3):148-55. DOI: 10.1179/1973947813Y.0000000071. View

17.

Pallon J, Sundqvist M, Hedin K . A 2-year follow-up study of patients with pharyngotonsillitis. BMC Infect Dis. 2018; 18(1):3. PMC: 5749013. DOI: 10.1186/s12879-017-2917-4. View

18.

Elsammak M, Hanna H, Ghazal A, Edeen F, Kandil M . Diagnostic value of serum procalcitonin and C-reactive protein in Egyptian children with streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2006; 25(2):174-6. DOI: 10.1097/01.inf.0000199273.37314.b2. View

19.

Pallon J, Roost M, Sundqvist M, Hedin K . The aetiology of pharyngotonsillitis in primary health care: a prospective observational study. BMC Infect Dis. 2021; 21(1):971. PMC: 8446737. DOI: 10.1186/s12879-021-06665-9. View

20.

Schneider J, Boehme C, Borisch B, Dittrich S . Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections. J Med Econ. 2020; 23(7):673-682. DOI: 10.1080/13696998.2020.1736872. View